Loading...
•
Dec 31, 2019
Merit Medical Q4 2019 Earnings Report
Merit Medical reported a revenue increase of 10.6% and a non-GAAP EPS of $0.40 for Q4 2019.
Key Takeaways
Merit Medical reported Q4 2019 worldwide revenue of $257.9 million, a 10.6% increase over Q4 2018. The GAAP loss per share was $(0.08), while the non-GAAP EPS was $0.40. The company provided FY 2020 guidance, estimating net sales between $1,044 million and $1,064 million and non-GAAP EPS between $1.58 and $1.68.
Q4 2019 worldwide revenue reached $257.9 million, a 10.6% increase compared to Q4 2018.
Core revenue on a comparable, constant currency basis increased by 8.5% over Q4 2018.
GAAP loss per share for Q4 2019 was $(0.08), compared to GAAP EPS of $0.16 in Q4 2018.
Non-GAAP EPS for Q4 2019 was $0.40, compared to $0.48 in Q4 2018.
Revenue by Segment
Forward Guidance
Merit Medical provided financial guidance for the year ending December 31, 2020, estimating net sales between $1,044 million and $1,064 million and non-GAAP EPS between $1.58 and $1.68. This guidance does not include any anticipated impact of the coronavirus outbreak.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...